Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

SourceAllECBSEC EDGARWhite HouseFederal ReserveBank of EnglandDOJBank of Japan
TopicAllenforcementfilingsmonetarypolicy

2425 items · filings · clear filters

  • SEC EDGARfilings
    8-K - Highlands REIT, Inc. (0001661458) (Filer)

    Highlands REIT, Inc. filed a Form 8-K on July 13, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - BITMINE IMMERSION TECHNOLOGIES, INC. (0001829311) (Filer)

    Bitmine Immersion Technologies, Inc. filed a Form 8-K on July 13, 2026, reporting amendments to its articles of incorporation or bylaws and a fiscal year change, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Voyager Therapeutics, Inc. (0001640266) (Filer)

    Voyager Therapeutics, Inc. filed a Form 8-K with the SEC on July 13 2026, reporting under Item 8.01 (Other Events) as accession number 0001104659-26-082906.

  • SEC EDGARfilings
    8-K - NORTHERN OIL & GAS, INC. (0001104485) (Filer)

    Northern Oil & Gas, Inc. filed a Form 8-K on July 13 2026, reporting its results of operations, financial condition, and including financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Q32 Bio Inc. (0001661998) (Filer)

    Q32 Bio Inc. filed a Form 8-K on July 13, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGARfilings
    8-K - Trade Desk, Inc. (0001671933) (Filer)

    Trade Desk, Inc. filed an 8-K reporting the departure and appointment of certain directors and officers, related compensatory arrangements, and providing its financial statements and accompanying exhibits.

  • SEC EDGARfilings
    8-K - Edgewise Therapeutics, Inc. (0001710072) (Filer)

    Edgewise Therapeutics filed a Form 8-K on July 13, 2026, reporting completion of an acquisition or asset disposition, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Plum Acquisition Corp. III (0001845550) (Filer)

    Plum Acquisition Corp. III filed a Form 8-K with the SEC on July 13, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGARfilings
    8-K - Shift4 Payments, Inc. (0001794669) (Filer)

    Shift4 Payments, Inc. filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, and the inclusion of financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - GoPro, Inc. (0001500435) (Filer)

    GoPro, Inc. filed a Form 8-K on July 13, 2026, reporting entry into a material definitive agreement and the creation of a direct financial obligation or off-balance-sheet arrangement.

  • SEC EDGARfilings
    8-K - Medalist Diversified, Inc. (0001654595) (Filer)

    Medalist Diversified, Inc. submitted a Form 8-K filing on July 13 2026 (Accession No. 0001104659-26-082898), which includes Item 8.01 covering other events and Item 9.01 presenting financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Ocugen, Inc. (0001372299) (Filer)

    Ocugen, Inc. filed a Form 8-K on July 13 2026 (Accession No. 0001104659-26-082897), reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGARfilings
    8-K - Victory Capital Holdings, Inc. (0001570827) (Filer)

    Victory Capital Holdings, Inc. filed a Form 8-K with the SEC on July 13, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGARfilings
    8-K - OmniAb, Inc. (0001846253) (Filer)

    OmniAb, Inc. filed a Form 8-K reporting the departure and appointment of certain officers and directors, including details of compensatory arrangements for the appointed officers.

  • SEC EDGARfilings
    8-K - Third Coast Bancshares, Inc. (0001781730) (Filer)

    Third Coast Bancshares, Inc. filed a Form 8-K on July 13, 2026, reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.

  • SEC EDGARfilings
    8-K - BNB PLUS CORP. (0000744452) (Filer)

    BNB Plus Corp filed a Form 8-K on July 13, 2026, reporting a notice of delisting or failure to satisfy a continued listing rule, a transfer of listing, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Astrana Health, Inc. (0001083446) (Filer)

    Astrana Health, Inc. filed a Form 8-K on July 13, 2026 (Accession No. 0001104659-26-082892), containing a Regulation FD disclosure under Item 7.01 and financial statements with related exhibits under Item 9.01.

  • SEC EDGARfilings
    8-K - Matinas BioPharma Holdings, Inc. (0001582554) (Filer)

    Matinas BioPharma Holdings filed a Form 8-K reporting entry into a material definitive agreement, unregistered equity sales, modifications to security holder rights, changes in control, director/officer departures and appointments, amendments to governing documents, and a Regulation FD disclosure.

  • SEC EDGARfilings
    8-K - MALIBU BOATS, INC. (0001590976) (Filer)

    Malibu Boats, Inc. filed an 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Strategy Inc (0001050446) (Filer)

    Strategy Inc. filed a Form 8-K with the SEC on July 13, 2026, containing a Regulation FD disclosure (Item 7.01) and other events (Item 8.01).

  • SEC EDGARfilings
    8-K - Strive, Inc. (0001920406) (Filer)

    Strive, Inc. submitted a Form 8-K filing on July 13, 2026, reporting an Item 8.01 “Other Events” disclosure, with accession number 0001628280-26-047938 and a document size of 298 KB.

  • SEC EDGARfilings
    8-K/A - Picard Medical, Inc. (0002030617) (Filer)

    Picard Medical, Inc. filed an amended Form 8-K on July 13, 2026 (Accession No. 0001437749-26-023381), reporting other events under Item 8.01 and providing financial statements and exhibits under Item 9.01.

  • SEC EDGARfilings
    8-K - Hillman Solutions Corp. (0001822492) (Filer)

    Hillman Solutions Corp filed a Form 8-K on July 13, 2026, containing Item 2.02 (results of operations and financial condition), Item 7.01 (Regulation FD disclosure), and Item 9.01 (financial statements and exhibits).

  • SEC EDGARfilings
    8-K - Alto Neuroscience, Inc. (0001999480) (Filer)

    Alto Neuroscience, Inc. filed a Form 8-K on July 13, 2026, disclosing its results of operations and financial condition (Item 2.02) and reporting other events (Item 8.01).

  • SEC EDGARfilings
    8-K - PLUG POWER INC (0001093691) (Filer)

    Plug Power Inc. filed a Form 8-K on July 13, 2026, disclosing a material definitive agreement, its recent results of operations and financial condition, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - FIRST HAWAIIAN, INC. (0000036377) (Filer)

    First Hawaiian, Inc. filed a Form 8-K on July 13 2026, reporting results of operations and financial condition (Item 2.02), a Regulation FD disclosure (Item 7.01), other events (Item 8.01), and accompanying financial statements and exhibits (Item 9.01).

  • SEC EDGARfilings
    8-K - RESIDEO TECHNOLOGIES, INC. (0001740332) (Filer)

    Resideo Technologies, Inc. filed a Form 8-K on July 13, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits, under accession number 0001213900-26-077351.

  • SEC EDGARfilings
    8-K - TRICO BANCSHARES / (0000356171) (Filer)

    Trico Bancshares filed a Form 8-K on July 13, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Armata Pharmaceuticals, Inc. (0000921114) (Filer)

    Armata Pharmaceuticals, Inc. filed a Form 8-K on July 13, 2026, containing a Regulation FD disclosure (Item 7.01) and financial statements with related exhibits (Item 9.01).

  • SEC EDGARfilings
    8-K - Q32 Bio Inc. (0001661998) (Filer)

    Q32 Bio Inc. filed a Form 8-K on July 13, 2026 (Accession No. 0001193125-26-301464), containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.